KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Other Non-Current Liabilities (2017 - 2024)

Cardlytics' Other Non-Current Liabilities history spans 6 years, with the latest figure at $17000.0 for Q3 2024.

  • For Q3 2024, Other Non-Current Liabilities changed N/A year-over-year to $17000.0; the TTM value through Sep 2024 reached $17000.0, changed N/A, while the annual FY2023 figure was $73000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $17000.0 in Q3 2024 per CDLX's latest filing, down from $1.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.6 million in Q4 2021 to a low of $17000.0 in Q3 2024.
  • Average Other Non-Current Liabilities over 5 years is $1.2 million, with a median of $679000.0 recorded in 2020.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 570.1% in 2021, then crashed 96.91% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $679000.0 in 2020, then surged by 570.1% to $4.6 million in 2021, then tumbled by 99.54% to $21000.0 in 2022, then soared by 247.62% to $73000.0 in 2023, then plummeted by 76.71% to $17000.0 in 2024.
  • Per Business Quant, the three most recent readings for CDLX's Other Non-Current Liabilities are $17000.0 (Q3 2024), $1.7 million (Q1 2024), and $73000.0 (Q4 2023).